Future development of chimeric antigen receptor T cell therapies for patients suffering from malignant glioma
PB Watchmaker, M Colton… - Current opinion in …, 2022 - journals.lww.com
PB Watchmaker, M Colton, PL Pineo-Cavanaugh, H Okada
Current opinion in oncology, 2022•journals.lww.comFuture development of chimeric antigen receptor T cell thera... : Current Opinion in Oncology
Future development of chimeric antigen receptor T cell therapies for patients suffering from
malignant glioma : Current Opinion in Oncology Log in or Register Subscribe to journalSubscribe
Get new issue alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle
navigation Subscribe Register Login Articles & Issues For Authors Journal Info Advanced Search
November 2022 - Volume 34 - Issue 6 Previous Article Next Article BRAIN AND NERVOUS …
Future development of chimeric antigen receptor T cell therapies for patients suffering from
malignant glioma : Current Opinion in Oncology Log in or Register Subscribe to journalSubscribe
Get new issue alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle
navigation Subscribe Register Login Articles & Issues For Authors Journal Info Advanced Search
November 2022 - Volume 34 - Issue 6 Previous Article Next Article BRAIN AND NERVOUS …
Summary
The discoveries highlighted in this review will aid the development of CAR cells that are safer, more resilient against immunosuppressive signals in the CNS, and able to specifically target intracranial tumour cells.
Lippincott Williams & Wilkins